Table 2.
Multivariate analysis for OS and LFS in 164 MDS patients who had cytogenetic data at diagnosis
| Variable | OS, 95% CI | LFS, 95% CI | ||||||
|---|---|---|---|---|---|---|---|---|
| HR | Lower | Upper | P | HR | Lower | Upper | P | |
| Age* | 1.024 | 1.007 | 1.040 | .005 | 1.012 | 0.997 | 1.028 | .114 |
| IPSS-R† | 1.418 | 1.116 | 1.803 | .004 | 1.388 | 1.091 | 1.766 | .008 |
| ASXL1 | 1.277 | 0.684 | 2.386 | .443 | 1.875 | 1.037 | 3.388 | .037 |
| SRSF2 | 0.766 | 0.372 | 1.579 | .471 | 0.710 | 0.355 | 1.420 | .333 |
| TP53 | 3.108 | 1.254 | 7.702 | .014 | 3.239 | 1.299 | 8.077 | .012 |
| ZRSR2 | 1.382 | 0.683 | 2.794 | .368 | 1.023 | 0.508 | 2.060 | .949 |
| Higher LSC4 score‡ | 3.452 | 1.875 | 6.356 | <.001 | 3.792 | 2.076 | 6.929 | <.001 |
P < .05 is considered statistically significant. Only variables with P ≤ .05 in univariate analysis were incorporated into the multivariate Cox proportional hazard regression analysis.
CI, confidence interval; HR, hazard ratio.
Continuous variable.
IPSS-R risk groups: very good, good, intermediate, poor, and very poor.
High vs low LSC4 risk scores (median as cutoff).